"Anorexia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The lack or loss of APPETITE accompanied by an aversion to food and the inability to eat. It is the defining characteristic of the disorder ANOREXIA NERVOSA.
Descriptor ID |
D000855
|
MeSH Number(s) |
C23.888.821.108
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Anorexia".
Below are MeSH descriptors whose meaning is more specific than "Anorexia".
This graph shows the total number of publications written about "Anorexia" by people in this website by year, and whether "Anorexia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
1995 | 2 | 0 | 2 |
1996 | 1 | 1 | 2 |
1997 | 0 | 1 | 1 |
1998 | 2 | 1 | 3 |
2000 | 1 | 1 | 2 |
2001 | 1 | 1 | 2 |
2002 | 2 | 1 | 3 |
2003 | 1 | 0 | 1 |
2005 | 2 | 0 | 2 |
2006 | 3 | 0 | 3 |
2007 | 0 | 1 | 1 |
2009 | 1 | 0 | 1 |
2010 | 2 | 2 | 4 |
2011 | 2 | 3 | 5 |
2012 | 2 | 0 | 2 |
2013 | 0 | 3 | 3 |
2014 | 2 | 3 | 5 |
2015 | 0 | 1 | 1 |
2016 | 1 | 0 | 1 |
2017 | 0 | 3 | 3 |
2018 | 0 | 1 | 1 |
2019 | 0 | 1 | 1 |
2021 | 2 | 1 | 3 |
2022 | 1 | 2 | 3 |
2023 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anorexia" by people in Profiles.
-
An excitatory projection from the basal forebrain to the ventral tegmental area that underlies anorexia-like phenotypes. Neuron. 2024 Feb 07; 112(3):458-472.e6.
-
Benefits and risks of off-label olanzapine use for symptom management in cancer patients-a case report. Ann Palliat Med. 2023 May; 12(3):600-606.
-
Hyperactivity of a midbrain dopamine to 5-HT circuit causes anorexia. J Mol Cell Biol. 2022 08 26; 14(5).
-
A D2 to D1 shift in dopaminergic inputs to midbrain 5-HT neurons causes anorexia in mice. Nat Neurosci. 2022 05; 25(5):646-658.
-
Do Patients Benefit from a Trial of Corticosteroids at the End of Life? Curr Treat Options Oncol. 2022 06; 23(6):796-805.
-
Gai/o-coupled Htr2c in the paraventricular nucleus of the hypothalamus antagonizes the anorectic effect of serotonin agents. Cell Rep. 2021 11 16; 37(7):109997.
-
Supportive care for the prevention of nausea, vomiting and anorexia in a phase 1B study of selinexor in advanced cancer patients: an exploratory study. Invest New Drugs. 2022 02; 40(1):124-133.
-
Acupuncture for Cancer-Related Anorexia: a Review of the Current Evidence. Curr Oncol Rep. 2021 05 05; 23(7):82.
-
Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1-2 trial. Lancet Oncol. 2019 10; 20(10):1432-1443.
-
Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial. Lancet Oncol. 2018 04; 19(4):461-473.